TABLE 1.
Parameters | Control | Vitamin B6 deficient | Vitamin B6 treated |
A. Cardiomyocytes [Ca2+]i | |||
Basal [Ca2+]i, nM | 121 ± 8.6 | 118 ± 4.4 | 123 ± 6.4 |
Increase in [Ca2+]i due to 30 mM to KCl, nM | 86 ± 5.1 | 129 ± 8.1* | 88 ± 5.5† |
Increase in [Ca2+]i due to 100 μM ATP, nM | 69 ± 4.7 | 33 ± 4.5* | 64 ± 4.2† |
Increase in [Ca2+]i due to 10 μM ATP, nM | 37 ± 5.8 | 12 ± 3.6* | – |
B. SL ATP binding | |||
ATP binding at 2 nM ATP, pmol/μg protein | 3.2 ± 0.25 | 2.3 ± 0.17* | – |
ATP binding at 10 nM ATP, pmol/μg protein | 14.0 ± 0.89 | 9.1 ± 1.2* | – |
Control and vitamin B6 deficient rats were fed vitamin B6-containing or vitamin B6-deficient diet for 8 weeks before isolating cardiomyocytes or sarcolemma from the heart. For vitamin B6 treated group, 8 weeks vitamin B6-deficient rats were injected pyridoxin hydrochloride (10 mg/kg; i.p.) 24 h before the experiment. The data are taken from our paper (Dakshinamurti et al., 1998). *P < 0.05 vs. control; †P < 0.05 vs. vitamin B6 deficient group.